1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Increasing prevalence of Coronary Artery Disease (CAD)
4.1.2. Increasing demand for minimally invasive treatments
4.1.3. Technological advancements in interventional cardiology devices
4.1.4. Growing geriatric population
4.2. Restraints & Challenges
4.2.1. Reimbursement issues in emerging economies
4.2.2. Stringent regulatory approvals
4.3. Opportunities
4.3.1. Emergence of bioresorbable stents
4.3.2. Increasing Healthcare Expenditure in developing economies
5. North America Interventional Cardiology Devices Market– By Product Type
5.1. Stents
5.1.1. Bioresorbable Stents
5.1.2. Bare Metal Stents
5.1.3. Drug Eluting Stents
5.2. Catheters
5.2.1. Pulmonary Artery Catheters
5.2.2. IVUS (Intravascular Ultrasound Catheters)
5.2.3. PTCA (Percutaneous Transluminal Coronary Angioplasty) Guiding Catheters
5.2.4. Angiography Catheters
5.3. PTCA Balloons
5.3.1. Normal Balloons
5.3.2. Others
5.4. PTCA Guide Wires
5.5. Interventional Cardiology Systems
5.5.1. IVUS Systems
5.5.2. FFR (Fractional Flow Reserve) Systems
5.5.3. Optical Coherence Tomography (OCT) Systems
5.6. Others
6. North America Interventional Cardiology Devices Market- By End-users
6.1. Hospitals
6.2. Clinics
6.3. Ambulatory Surgical Centers
6.4. Others
7. North America Interventional Cardiology Devices Market– By Geography
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
8. North America Interventional Cardiology Devices Market– Company Profiles
8.1. Abbott Laboratories
8.2. Cordis Corporation
8.3. Medtronic Inc.
8.4. Biosensors International Ltd
8.5. B. Braun Melsungen
8.6. Johnson & Johnson
8.7. Boston Scientific Corporation
8.8. Terumo Medical Corporation
8.9. Acrostak (Schweiz) AG
8.10. Biotronik
8.11. C.R. Bard
8.12. St. Jude Medical
8.13. Cardinal Health
8.14. IVascular
9. North America Interventional Cardiology Devices Market- Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
11. Appendix
11.1. List of tables
11.2. List of figures
